DCM Shriram Fine Chemicals Q2 FY27 consolidated PAT at Rs (0.08) crore
Results$DSFCL

DCM Shriram Fine Chemicals Q2 FY27 consolidated PAT at Rs (0.08) crore

DCM Shriram Fine Chemicals’ consolidated total income was Rs 93.37 cr and PAT Rs (0.0765) cr in Q2 FY27, versus Rs 97.58 cr and Rs (2.53) cr a year earlier.

DCM Shriram Fine Chemicals Ltd
DCM Shriram Fine Chemicals LtdReviewed and published by · How we report
3 min read
dcm shriram fine chemicalsq2 fy27 resultsearningschemicals
ShareWhatsAppXLinkedIn

Key takeaways

  • Revenue from operations was Rs 89.97 cr vs Rs 96.90 cr in Q2 FY26.
  • Total income stood at Rs 93.37 cr vs Rs 97.58 cr a year earlier.
  • Total expenses were Rs 94.03 cr vs Rs 100.78 cr in Q2 FY26.
  • PAT was a loss of Rs (0.0765) cr vs loss of Rs (2.53) cr in Q2 FY26.
  • Basic and diluted EPS was Rs (0.01) vs Rs (0.29) in the year-ago quarter.

Q2 FY27 · consolidated

MetricSep 2026Sep 2025Change
RevenueRs 89.97 crRs 96.90 cr-7.1%
PATRs (0.0765) crRs (2.53) cr+97.0%

As reported in the filing. Figures are transcribed, not computed.

What the numbers show

  • Net margin was -0.09% of revenue, up 252 bps from -2.61%.
  • Cost of materials took 69.1% of revenue, against 56.7% a year earlier.

• Revenue from operations (consolidated, Q2 FY27): Rs 89.97 cr vs Rs 96.90 cr in Q2 FY26
• Total income (consolidated, Q2 FY27): Rs 93.37 cr vs Rs 97.58 cr in Q2 FY26
• Total expenses (consolidated, Q2 FY27): Rs 94.03 cr vs Rs 100.78 cr in Q2 FY26
• Cost of materials consumed (consolidated, Q2 FY27): Rs 62.16 cr vs Rs 54.92 cr in Q2 FY26
• Changes in inventories (consolidated, Q2 FY27): Rs (2.89) cr vs Rs 3.51 cr in Q2 FY26
• Employee benefits expense (consolidated, Q2 FY27): Rs 11.67 cr vs Rs 12.50 cr in Q2 FY26
• Finance costs (consolidated, Q2 FY27): Rs 0.7249 cr vs Rs 0.2247 cr in Q2 FY26
• Depreciation and amortisation expenses (consolidated, Q2 FY27): Rs 1.91 cr vs Rs 2.17 cr in Q2 FY26
• Other expenses (consolidated, Q2 FY27): Rs 20.45 cr vs Rs 27.46 cr in Q2 FY26
• Profit / (Loss) before tax – PBT (consolidated, Q2 FY27): Rs (0.6637) cr vs Rs (3.20) cr in Q2 FY26
• Tax expenses / (credit) total (consolidated, Q2 FY27): Rs (0.5872) cr vs Rs (0.6724) cr in Q2 FY26
• Profit / (Loss) after tax – PAT (consolidated, Q2 FY27): Rs (0.0765) cr vs Rs (2.53) cr in Q2 FY26
• Basic and diluted EPS (consolidated, Q2 FY27): Rs (0.01) vs Rs (0.29) in Q2 FY26

According to the consolidated statement of unaudited financial results for the quarter ended 30-09-2026 on the statement of financial results, revenue from operations for the quarter was Rs 89.97 cr, compared with Rs 96.90 cr in the corresponding quarter a year earlier. Including other income of Rs 3.39 cr (vs Rs 0.6806 cr in Q2 FY26), total income stood at Rs 93.37 cr against Rs 97.58 cr in the year-ago quarter.

On the cost side, total expenses were Rs 94.03 cr in Q2 FY27, down from Rs 100.78 cr in Q2 FY26. Within this, cost of materials consumed increased to Rs 62.16 cr from Rs 54.92 cr, while changes in inventories of finished goods and work-in-progress moved to Rs (2.89) cr from Rs 3.51 cr. Employee benefits expense was Rs 11.67 cr versus Rs 12.50 cr a year earlier. Finance costs rose to Rs 0.7249 cr from Rs 0.2247 cr, and depreciation and amortisation expenses were Rs 1.91 cr compared with Rs 2.17 cr. Other expenses declined to Rs 20.45 cr from Rs 27.46 cr.

The company reported a consolidated loss before tax of Rs (0.6637) cr for Q2 FY27, compared with a loss before tax of Rs (3.20) cr in Q2 FY26. After a total tax credit of Rs (0.5872) cr versus Rs (0.6724) cr in the prior-year quarter, consolidated PAT for the quarter was a loss of Rs (0.0765) cr, compared with a loss of Rs (2.53) cr in the same quarter last year. Basic and diluted earnings per share for the quarter were reported at Rs (0.01), versus Rs (0.29) in Q2 FY26, as per the statement of financial results.

Track DCM Shriram Fine Chemicals Ltd

Cruxal reads every DCM Shriram Fine Chemicals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Get every filing that moves a stock

One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.

Cruxal publishes market coverage for information only. Nothing here is investment advice.